366 related articles for article (PubMed ID: 28151478)
1. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
[TBL] [Abstract][Full Text] [Related]
2. Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination.
Liao Y; Xia X; Liu N; Cai J; Guo Z; Li Y; Jiang L; Dou QP; Tang D; Huang H; Liu J
Oncogene; 2018 Apr; 37(14):1896-1910. PubMed ID: 29353883
[TBL] [Abstract][Full Text] [Related]
3. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.
Chen ST; Okada M; Nakato R; Izumi K; Bando M; Shirahige K
J Biol Chem; 2015 Aug; 290(35):21713-23. PubMed ID: 26175158
[TBL] [Abstract][Full Text] [Related]
4. Selective degradation of AR-V7 to overcome castration resistance of prostate cancer.
Liu Y; Yu C; Shao Z; Xia X; Hu T; Kong W; He X; Sun W; Deng Y; Liao Y; Huang H
Cell Death Dis; 2021 Sep; 12(10):857. PubMed ID: 34548474
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
6. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor.
Burska UL; Harle VJ; Coffey K; Darby S; Ramsey H; O'Neill D; Logan IR; Gaughan L; Robson CN
J Biol Chem; 2013 Nov; 288(45):32641-32650. PubMed ID: 24056413
[TBL] [Abstract][Full Text] [Related]
8. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide.
Xia X; Huang C; Liao Y; Liu Y; He J; Guo Z; Jiang L; Wang X; Liu J; Huang H
J Exp Clin Cancer Res; 2019 May; 38(1):220. PubMed ID: 31126320
[TBL] [Abstract][Full Text] [Related]
10. Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling.
Liu N; Guo Z; Xia X; Liao Y; Zhang F; Huang C; Liu Y; Deng X; Jiang L; Wang X; Liu J; Huang H
Eur J Pharmacol; 2019 Mar; 846():1-11. PubMed ID: 30639309
[TBL] [Abstract][Full Text] [Related]
11. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
Yu P; Duan X; Cheng Y; Liu C; Chen Y; Liu W; Yin B; Wang X; Tao Z
Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
[TBL] [Abstract][Full Text] [Related]
12. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
[TBL] [Abstract][Full Text] [Related]
14. Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.
Gong Y; Wang D; Dar JA; Singh P; Graham L; Liu W; Ai J; Xin Z; Guo Y; Wang Z
Endocrinology; 2012 Dec; 153(12):5716-25. PubMed ID: 23041672
[TBL] [Abstract][Full Text] [Related]
15. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.
Vaden JH; Bhattacharyya BJ; Chen PC; Watson JA; Marshall AG; Phillips SE; Wilson JA; King GD; Miller RJ; Wilson SM
Mol Neurodegener; 2015 Jan; 10():3. PubMed ID: 25575639
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.
Levina E; Ji H; Chen M; Baig M; Oliver D; Ohouo P; Lim CU; Schools G; Carmack S; Ding Y; Broude EV; Roninson IB; Buttyan R; Shtutman M
Oncotarget; 2015 May; 6(15):13088-104. PubMed ID: 26036626
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
19. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]